Literature DB >> 27154140

The European Medicines Agency is still too close to industry.

Silvio Garattini1.   

Abstract

Mesh:

Year:  2016        PMID: 27154140     DOI: 10.1136/bmj.i2412

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Market approval for drugs in the EU: time to change direction?

Authors:  Alessandro Curto; Katelijne van de Vooren; Livio Garattini
Journal:  Eur J Health Econ       Date:  2017-11

2.  European Medicines Agency: leave the UK but remain the same.

Authors:  Livio Garattini; Alessandro Curto
Journal:  J R Soc Med       Date:  2016-09       Impact factor: 5.344

3.  Evaluation in alcohol use disorders - insights from the nalmefene experience.

Authors:  Florian Naudet; Clément Palpacuer; Rémy Boussageon; Bruno Laviolle
Journal:  BMC Med       Date:  2016-08-18       Impact factor: 8.775

4.  Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?

Authors:  Nicole Grössmann; Claudia Wild
Journal:  ESMO Open       Date:  2017-01-31

5.  Trust and willingness towards COVID-19 vaccine uptake: a mixed-method study in Ghana, 2021.

Authors:  Joshua Amo-Adjei; Anastasiia Nurzhynska; Ruth Essuman; Anna-Leena Lohiniva
Journal:  Arch Public Health       Date:  2022-02-21

6.  Patients not patents: Drug research and development as a public enterprise.

Authors:  Peter C Gøtzsche
Journal:  Eur J Clin Invest       Date:  2018-01-05       Impact factor: 4.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.